1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIGMS-Specific SBIR Guidance (within NIH SBIR/STTR) is sponsored by National Institute of General Medical Sciences (NIGMS), NIH. NIGMS supports innovative SBIR projects that benefit research communities related to its mission. These are investigator-initiated, allowing applicants to propose their research, methodology, and commercialization path.
Applications are accepted in most scientific areas supported by NIGMS.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: U.S.-based small businesses (fewer than 500 employees). Must meet NIH SBIR/STTR eligibility requirements. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: ~$300,000 for 6–12 months; Phase II: ~$2M+ for up to 2 years. Budget requests exceeding statutory limitations may be considered for SBA-approved waiver topics. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIGMS-Specific SBIR Guidance (within NIH SBIR/STTR) is funded by National Institute of General Medical Sciences (NIGMS), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articlePAR-27-054 and PAR-27-055 replace COBRE's Phase 1-2-3 model with two tracks: a 15-year Development-Expansion-Sustainability path and a 10-year Expansion-Sustainability path. At $1.5 million per year in direct costs across 23 states and Puerto Rico, with new research cores prohibited in the final phase and eligibility capped at three active awards per institution, the track you claim is the most consequential choice in the application.
Read article